Biomarker Profiling in Individuals at Risk for Prion Disease

Abroad (travel likely)Recruiting

Conditions

CJD (Creutzfeldt Jakob Disease) · Prion Diseases · GSS · FFI · Familial Fatal Insomnia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Alzheimer's Clinical and Translational Research Unit, Charlestown, Massachusetts, United States
Contact: Study coordinator (Sophia D'Alessandro) · sedalessandro@mgh.harvard.edu · 617-726-4026
Contact: Study coordinator (Alison McManus, DNP) · AJMCMANUS@mgh.harvard.edu · 6176434848
Contact: Principal Investigator (Steven E Arnold, MD)

Study leads

Steven E Arnold, MD
Principal Investigator
MGH

View source on ClinicalTrials.gov Contact study team (email)